0001209191-21-059512.txt : 20211005
0001209191-21-059512.hdr.sgml : 20211005
20211005165311
ACCESSION NUMBER: 0001209191-21-059512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211005
DATE AS OF CHANGE: 20211005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crystal Adam
CENTRAL INDEX KEY: 0001825445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 211307440
MAIL ADDRESS:
STREET 1: C4 THERAPEUTICS, INC.
STREET 2: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-01
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001825445
Crystal Adam
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Medical Officer
Common Stock
2021-10-01
4
M
0
15000
4.98
A
15000
D
Common Stock
2021-10-01
4
S
0
1712
44.2502
D
13288
D
Common Stock
2021-10-01
4
S
0
8176
45.3233
D
5112
D
Common Stock
2021-10-01
4
S
0
5112
45.9935
D
0
D
Stock Option (Right to Buy)
4.98
2021-10-01
4
M
0
15000
0.00
D
2030-07-02
Common Stock
15000
168108
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.57 to $44.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.845. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.89 to $46.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020.
/s/ Jolie M. Siegel, Attorney-in-Fact
2021-10-05